Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors

Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors

US Patent 10323022 · Granted Jun 18, 2019

Estimated economic value: $181,885,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions2025
Fused ring heteroaryl compounds as RIPK1 inhibitors2025
Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases2025
Heterocyclic compounds and their use for treatment of helminthic infections and 2025
Fused ring heteroaryl compounds and use thereof2025
FGFR3 inhibitor compounds2025
FGFR3 inhibitor compounds2025
Protein tyrosine phosphatase inhibitors2025
Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kin2024
Antiproliferative compounds and methods of use thereof2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024